AccuGenomics is currently recruiting lung cancer patients for clinical trials of their Lung Cancer Risk Test
Global Cancer Consortium
Editor’s Note December 27, 2012
With a new year upon us, we are reminded of the year that is now coming to a close. 2011 has brought some amazing advancements in the healthcare and life science industry. […]
Anavex Life Sciences Challenges the Basic Assumptions In Treating Alzheimer’s Disease
The company’s lead drug candidate for Alzheimer’s Disease (AD), ANAVEX 2-73, has successfully completed a Phase 1 single ascending dose clinical trial.
Vigilant Biosciences Aims to Lower Oral Cancer Mortality with Simple Screening Test
Nearly 40 percent of oral cancer patients will die within five years of diagnosis.
Mirna Therapeutics Uses Synthetic miRNA to Fight Disease
Researchers discovered that miRNA plays an important role in a process known as transcription. .Since its miRNA is a mimic, it has the same sequence as the natural miRNA found in cells.
Excelimmune Optimizes the Natural Power of the Immune System
MRSA, which is commonly acquired through contact within the community, is resistant to most first-line antimicrobials on the market.
This Week in Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
This Week in Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
